Analysts have recently evaluated Evolent Health and provided 12-month price targets. The average target is $14.4, accompanied by a high estimate of $16.00 and a low estimate of $13.00. Observing a ...

Analysts have recently evaluated Bicycle Therapeutics and provided 12-month price targets. The average target is $22.0, ...